Copyright West LLC. Minimum 15 minutes delayed.

Investors & Media

Events & Presentations

Featured Events

Date Event Details
Summary Toggle Nov 9, 2018 8:00 AM EST

2018 R&D Day

Upcoming Events

Date Event Details Remind Me
Summary Toggle Nov 27, 2018 2:45 PM EST

Evercore ISI HealthCONx

Archived Events

Date Event Details
Summary Toggle Nov 15, 2018

Dicerna Pharmaceuticals Corporate Overview

Summary Toggle Nov 14, 2018 4:40 PM GMT

Jefferies 2018 London Healthcare Conference

Summary Toggle Nov 13, 2018 11:00 AM EST

Stifel 2018 Healthcare Conference

Summary Toggle Nov 9, 2018 8:00 AM EST

2018 R&D Day

Summary Toggle Nov 9, 2018

Dicerna HBV AASLD Poster 2018

Summary Toggle Nov 5, 2018 4:30 PM EST

Q3 2018 Earnings Conference Call

Summary Toggle Oct 25, 2018

Dicerna PHYOX ASN Poster 2018

Summary Toggle Oct 2, 2018 2:30 PM EDT

LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

Summary Toggle Oct 1, 2018 7:45 AM EDT

Cantor Fitzgerald Global Healthcare Conference

Summary Toggle Sep 5, 2018 1:45 PM EDT

HC Wainwright 20th Annual Global Investment Conference

Summary Toggle Aug 8, 2018 4:30 PM EDT

Q2 2018 Earnings Conference Call

Summary Toggle Jul 18, 2018

Dicerna Pharmaceuticals Corporate Overview July 2018

Summary Toggle Jun 5, 2018 2:30 PM EDT

Jefferies 2018 Global Healthcare Conference

Summary Toggle May 14, 2018 4:30 PM EDT

Q1 2018 Earnings Conference Call

Summary Toggle Apr 10, 2018

HC Wainwright Global Life Sciences Conference

Summary Toggle Mar 12, 2018

Cowen & Co. 38th Annual Healthcare Conference

Summary Toggle Mar 8, 2018 4:30 PM EST

Q4 2017 Earnings Conference Call

Summary Toggle Feb 14, 2018

LEERINK Partners 7th Annual Global Healthcare Conference

Summary Toggle Jan 30, 2018

NobleCon14 - Noble Capital Markets' Fourteenth Annual Investor Conference

Summary Toggle Jan 10, 2018

Dicerna Pharmaceuticals Corporate Overview January 2018

Summary Toggle Oct 26, 2017

GalXC TM RNAi Platform Enables Potent and Durable RNAi-Mediated Inhibition of Hepatitis B Virus in Preclinical Models

Summary Toggle Aug 15, 2017

Webinar: Dicerna Research Highlights from 12th International Workshop on Primary Hyperoxaluria

Let us know what you thought of the webinar by taking the brief survey

 

This event can be viewed in the following languages:

Summary Toggle Jul 15, 2017

DCR-PHXC:A new approach for treating all Primary Hyperoxalurias by inhibiting LDHA

Summary Toggle Jul 14, 2017

Oxalate Production in Primary Hyperoxaluria Types 1, 2 and 3 and the Role of LDH in the Liver

Summary Toggle Jul 14, 2017

PHYOS: An Observational Study of Patients with Primary Hyperoxaluria Type 1

Summary Toggle May 15, 2017

Dicerna US Tides May 2017 Presentation

Summary Toggle Apr 17, 2017

GalXC cGMP Manufacturing Experience Presentation

Summary Toggle Sep 8, 2016

Dicerna 2016 IPNA Poster

Summary Toggle Jun 29, 2016 8:30 AM EDT

Dicerna Investor Day 2016

Summary Toggle May 11, 2016

U.S. TIDES GalNAc-DsiRNA-EX Conjugates Presentation

Summary Toggle Feb 24, 2016

Asia TIDES GalNAc-DsiRNA-EX Conjugates Presentation

Summary Toggle Feb 26, 2007

Asia Tides 2017 Presentation - GalXC Research Update